Siriwardana, R.C.Niriella, M.A.Dassanayake, A.S.Liyanage, C.A.H.Gunetilleke, B.de Silva, H.J.2016-05-062016-05-062016Indian Journal of Gastroenterology. 2016; 35(3): 222-2240254-8860 (Print)0975-0711 (Electronic)http://repository.kln.ac.lk/handle/123456789/13008Indexed in MEDLINENon-alcoholic fatty liver disease (NAFLD) seems to recur in at least one third of patients transplanted for non-alcoholic steatohepatitis (NASH)-related cirrhosis. While, NASH recurrence does not seem to affect overall graft and patient survival up to 10 years, cardiovascular and infection-related morbidity and mortality seem to be increased in these patients. This report looks at the graft histology in patients who were transplanted for NASH-related cirrhosis after short-term follow up. We report a high prevalence of recurrent NAFLD in liver grafts post-transplant among five patients. The degree of steatosis noted among the recipients is alarming.en-USLiver CirrhosisLiver Cirrhosis-etiologyLiver Cirrhosis-surgeryNon-alcoholic Fatty Liver DiseaseNon-alcoholic Fatty Liver Disease-complicationsNon-alcoholic Fatty Liver Disease-epidemiologyPrevalenceLiver TransplantationFollow-Up StudiesArticle